Ethical Issues in Phase I Cancer Clinical Trials

By Peppercorn Jeffrey  

International Journal of Pharmaceutical Medicine, Vol. 20, Iss. 4, 2006-01 ,pp. : 233-242

Adis International

Access to resources Recommend Favorite

An update on bronchodilators in Phase I and II clinical trials

By Cazzola Mario   Rogliani Paola   Segreti Andrea   Matera Maria Gabriella  

Expert Opinion on Investigational Drugs, Vol. 21, Iss. 10, 2012-10 ,pp. : 1489-1501

Informa Healthcare

Access to resources Recommend Favorite

Phase I Clinical Studies of the Advanced Glycation End-product (AGE)-Breaker TRC4186: Safety, Tolerability and Pharmacokinetics in Healthy Subjects

By Chandra Kumar P.  

Clinical Drug Investigation, Vol. 29, Iss. 9, 2009-09 ,pp. : 559-575

Adis International

Access to resources Recommend Favorite

Who volunteers for phase I clinical trials? Influences of anxiety, social anxiety and depressive symptoms on self-selection and the reporting of adverse events

By Almeida Luis  

European Journal of Clinical Pharmacology, Vol. 64, Iss. 6, 2008-06 ,pp. : 575-582

Springer Publishing Company

Access to resources Recommend Favorite

Analysis of 312 studies of investigational medicinal products in healthy subjects to assess the impact of the European Union Clinical Trials Directive

By Malcolm B.   Steve W.  

International Journal of Pharmaceutical Medicine, Vol. 16, Iss. 4, 2002-08 ,pp. : 179-183

Adis International

Access to resources Recommend Favorite